Nuwellis (NUWE) Cash from Investing Activities (2011 - 2026)
Nuwellis' (NUWE) quarterly Cash from Investing Activities came in at -$9000.0 in Q2 2026, down 125.0% on a YoY basis from $36000.0 in Q2 2025, and up 96.83% quarter-over-quarter from -$284000.0 in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Cash from Investing Activities for 16 consecutive years, with -$9000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 125.0% year-over-year to -$9000.0; the trailing twelve-month figure through Jun 2026 stood at -$379000.0 (down 3345.45% YoY), and the FY2025 full-year result was -$90000.0, down 50.0% from the prior year.
- Cash from Investing Activities advanced to -$9000.0 in Q2 2026 per NUWE's latest filing, from -$284000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $14.8 million in Q4 2022 and bottomed at -$284000.0 in Q1 2026.
- Historically, Cash from Investing Activities has averaged $859705.9 across 5 years, with a median of -$22000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities jumped 4763.64% in 2023, then slumped 712.5% in 2025.
- Over 5 years, Cash from Investing Activities stood at $14.8 million in 2022, then sank by 99.76% to $36000.0 in 2023, then slumped by 163.89% to -$23000.0 in 2024, then soared by 152.17% to $12000.0 in 2025, then tumbled by 175.0% to -$9000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$9000.0, -$284000.0, and $12000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -9,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9,000.00 |
| Mar 31, 2026 | -284,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | -98,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Dec 31, 2024 | -23,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -24,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 36,000.00 |
| Sep 30, 2023 | -121,000.00 |
| Jun 30, 2023 | 513,000.00 |
| Mar 31, 2023 | -98,000.00 |
| Dec 31, 2022 | 14.83 Mn |
| Sep 30, 2022 | -22,000.00 |
| Jun 30, 2022 | -11,000.00 |
| Mar 31, 2022 | -70,000.00 |
| Dec 31, 2021 | -15.53 Mn |
| Sep 30, 2021 | -54,000.00 |
| Jun 30, 2021 | -81,000.00 |